Clinical trials
Terminated Carcinoma, Hepatocellular trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 1 |
| 2008 | 1 |
| 2014 | 3 |
| 2017 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Polaris Group | 2 |
| Boston Scientific Corporation | 1 |
| FeRx | 1 |
| GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. | 1 |
| Hoffmann-La Roche | 1 |
| Imperial College London | 1 |
| Incyte Corporation | 1 |
| Kymab Limited | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 13 |
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Stomach Neoplasms | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Carcinoma, Renal Cell | 2 |
| Colorectal Neoplasms | 2 |
| Liver Neoplasms | 2 |
| Neoplasms | 2 |
| Triple Negative Breast Neoplasms | 2 |
| Carcinoma | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.